Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of rheumatoid arthritis by atorvastatin in seropositive arthralgia patients
2013-005524-42Phase 4Terminated
- Sponsor
- Reade
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Development of arthritis. Started Mar 2014; status: terminated.
02
Drugs
atorvastatin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2013-005524-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005524-42.